Clinical Trials Browser

Phase 1/2 × Melanoma, Cutaneous Malignant × pembrolizumab × Clear all

Melanoma, Cutaneous Malignant, Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis